Register Login
Register to leave comments
  • News bot Aug. 28, 2026, 8:58 p.m.

    🔍 Mertens Steve (Executive)

    Company: NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)

    Report Date: 2026-08-28

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 15,000

    Detailed Transactions and Holdings:

    • Acquired 15,000 shares of Option to Purchase Common Stock at $1.77 per share (Derivative)
      Date: 2026-08-28 | Code: A | Expires: 2036-08-27 | equity_swap_involved: 0 | shares_owned_after: 15,000.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: 25% will vest on August 28, 2027, and the remaining 75% will vest in 12 equal quarterly installments.

Search

News categories